Peng Xia to Neoplasm Invasiveness
This is a "connection" page, showing publications Peng Xia has written about Neoplasm Invasiveness.
Connection Strength
0.037
-
Preclinical Evaluation of SCC244 (Glumetinib), a Novel, Potent, and Highly Selective Inhibitor of c-Met in MET-dependent Cancer Models. Mol Cancer Ther. 2018 04; 17(4):751-762.
Score: 0.037